Emanuela Felley‐Bosco

University Name
Country flag
Switzerland

Research Interests

Explore related searches

Contact this professor

LinkedIn
ORCID
Google Scholar

Articles (11)

The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition

Pleural mesothelioma (PM) is a cancer where epithelioid, biphasic and sarcomatoid histotypes are observed. Sarcomatoid PM is characterized by mesenchymal features. Multi-omics have been used to characterize the epithelial-to-mesenchymal (EMT) phenotype at the molecular level. We contribute to this effort by including the analysis of RNA editing. We extracted samples with the highest vs. lowest Epithelial score from two PM cohorts and observed increased RNA editing in introns and decreased RNA editing in 3′UTR upon EMT. The same was observed in primary PM primary cultures stratified by transcriptomics analysis into two groups, one of them enriched with mesenchymal features. Our data demonstrate that, as has been observed in other cancer types, RNA editing associates to EMT phenotype in PM.

Year:

2023

Heterogeneous <scp>RNA</scp> editing and influence of <scp>ADAR2</scp> on mesothelioma chemoresistance and the tumor microenvironment

We previously observed increased levels of adenosine‐deaminase‐acting‐on‐dsRNA (Adar)‐dependent RNA editing during mesothelioma development in mice exposed to asbestos. The aim of this study was to characterize and assess the role of ADAR‐dependent RNA editing in mesothelioma. We found that tumors and mesothelioma primary cultures have higher ADAR‐mediated RNA editing compared to mesothelial cells. Unsupervised clustering of editing in different genomic regions revealed heterogeneity between tumor samples as well as mesothelioma primary cultures. ADAR2 expression levels are higher in BRCA1‐associated protein 1 wild‐type tumors, with corresponding changes in RNA editing in transcripts and 3'UTR. ADAR2 knockdown and rescue models indicated a role in cell proliferation, altered cell cycle, increased sensitivity to antifolate treatment, and type‐1 interferon signaling upregulation, leading to changes in the microenvironment in vivo . Our data indicate that RNA editing contributes to mesothelioma heterogeneity and highlights an important role of ADAR2 not only in growth regulation in mesothelioma but also in chemotherapy response, in addition to regulating inflammatory response downstream of sensing nucleic acid structures.

Year:

2022

Collaborators (13)

Nadia Mercader

Full Professor

University of Bern

SWITZERLAND

Marc de Perrot

-

CANADA

Mark Robinson

Professor

University of Zurich

SWITZERLAND

Véronique Serre-Beinier

University Hospital of Geneva

SWITZERLAND

Stefanie Hiltbrunner

University of Fribourg

SWITZERLAND

Michele De Palma

Associate Professor

École Polytechnique Fédérale de Lausanne

SWITZERLAND

Christian Mosimann

The Helen and Arthur E. Johnson Chair for the Cardiac Research Director, Associate Professor of Pediatrics

-

UNITED STATES

Hubert Rehrauer

-

SWITZERLAND

Stephen Finn

Associate Professor

Trinity College Dublin School of Medicine

IRELAND

Licun Wu

University Health Network

CANADA

Alessandra Curioni-Fontecedro

Professor of Oncology

University of Fribourg

SWITZERLAND

Kathy Gately

Clinical Senior Lecturer

Trinity College Dublin

IRELAND

Isabelle Opitz

University Hospital of Zurich

SWITZERLAND
Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI